Watch

Tweet TWEET

Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, June 10

  Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday,
  June 10

            - William Blair 34^th Annual Growth Stock Conference -

         - Goldman Sachs 35^th Annual Global Healthcare Conference -

           - Webcasts Available Through Gilead Corporate Website -

William Blair Growth Stock Conference 2014 Goldman Sachs 35th Annual Global
Healthcare Conference 2014

Business Wire

FOSTER CITY, Calif. -- June 9, 2014

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from two upcoming investor conferences: the
William Blair 34^th Annual Growth Stock Conference in Chicago and the Goldman
Sachs 35^th Annual Global Healthcare Conference in Rancho Palos Verdes.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will
provide an overview of the company at the William Blair conference on Tuesday,
June 10 at 10:50 a.m. Central Time.

Robin L. Washington, Gilead’s Executive Vice President and Chief Financial
Officer, will provide an overview of the company at the Goldman Sachs
conference on Tuesday, June 10 at 10:00 a.m. Pacific Time.

To access the live webcast or a replay via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15 minutes
prior to the start of the presentation to ensure adequate time for any
software download that may be necessary to listen to the webcast. The replay
will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North and South America, Europe and Asia Pacific.

 For more information on Gilead Sciences, please visit www.gilead.com or call
   the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Contact:

Gilead Sciences
Patrick O’Brien, 650-522-1936
Investor Relations
 
Press spacebar to pause and continue. Press esc to stop.